An Australian study has shown that a hybrid closed-loop (HCL) insulin delivery system results in better glycaemic outcomes in people with type 1 diabetes (T1D) compared to user determined insulin dosing and self-monitoring of blood glucose. The results come from a six-month randomised controlled trial involving 120 adults with T1D at seven Australian centres, half ...
Hybrid closed loop system delivers glycaemic benefits: Australian RCT
By Michael Woodhead
29 Oct 2020